Categories: News

Sibannac, Inc. Provides Update on Operations

Scottsdale, Arizona–(Newsfile Corp. – October 3, 2023) – Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following:

After a fast-paced summer season of acquisitions and product developments, the Company is providing the following update on the status of our business operations and plans moving into 2024.

Immersive Brands

The acquisition of Immersive Brands under the leadership of Karl Gottschalk will be a focal point of operations and revenues as we move into the new year. Based in Oklahoma City, we will be manufacturing THC and Kratom products for direct sales as well as for white label customers. Immersive has industry leading tech in the manufacturing of THC pre-rolls and Kratom tinctures under our Let’s Go brand. We recently announced an initial order of 30,000 units of our Kratom shots to be distributed between Las Vegas and New York City.

Celebrity Influencers

The Company will be announcing new relationships with celebrity endorsers for its NOHO shot product. This will involve developing whitebrands as well as licensing of our main product line. We also have presented the NOHO shot to major retailers in the convenience store segment and are currently working with distributors to carry the shot at retail.

Canadian Retail with Allstar Health Brands (OTC Pink: ALST) and TYME Cannabis Co.

As the Company moves forward in the diligence process, we have up to 75 cannabis licenses in Canada to open retail locations. Under the proposed terms, Sibannac would acquire the fully operational location, which is profitable, as well as the option to acquire two additional locations that are completed and ready to open. We intend to bring our Kratom products to Canada to sell through the same retail locations.

The Kavern

Sibannac is slated to open our first Kava/Kratom bar in our home base of Scottsdale, Arizona. The bar, named, The Kavern, is slated to open at the end of 2023 and is currently being renovated in Scottsdale’s bustling Old Town district. In addition to Kratom beverages and tinctures, we will be offering THC gummies and beverages, the NOHO shot, as well as a line of supplements, all made in our Scottsdale-based lab, just minutes from our retail location.

About Sibannac

Sibannac, Inc. (OTC Pink: SNNC) is a Nevada corporation founded in 1999 and located in Scottsdale, Arizona. Sibannac currently specializes in creating and selling premium next generation wellness products in the consumer packaging goods space. In addition to mainstream supplements and its hangover shot, NOHO, the Company is producing Kratom and Hemp-derived Delta-8/9 products, and Amanita mushroom edibles for wholesale and retail sales and distribution. Sibannac provides contract manufacturing and white labeling services for independent firms and creates and manages its own brands from the concept phase through to distribution. Sibannac has opened its platform to outside clients to offer its marketing and brand-building assets, through its wholly owned subsidiaries, The Campus Co. and Immersive Brand Concepts.

More from Sibannac – For additional information and product updates, please follow us at The Campus Co. and follow us on Twitter at www.twitter.com/sibannacinc.

Media Contact: IR@theCampusCo.com

Cautionary Note Regarding Forward-Looking Statements.

This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Sibannac, Inc. (the “Company”), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/182676

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

2 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

3 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

3 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

4 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

6 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

6 hours ago